Chest
Volume 109, Issue 5, May 1996, Pages 1163-1168
Journal home page for Chest

Spirometry and Dyspnea in Patients With COPD: When Small Differences Mean Little

https://doi.org/10.1378/chest.109.5.1163Get rights and content

Objective

To determine when a difference in FEV1 is sufficiently large to be associated with a noticeable difference in dyspnea symptoms for patients with chronic lung disease.

Design

Cross-sectional analysis of 15 groups (n=112 patients, 832 contrasts).

Setting

Respiratory rehabilitation program.

Patients

Patients with COPD (mean FEV1=35% predicted).

Measures

Patients' perspectives assessed through subjective comparison ratings of dyspnea and of overall health. Relation between the FEV1 and patients' perspectives determined the smallest difference in spirometry that was associated with a noticeable difference in patients' symptoms.

Results

The FEV1 was moderately correlated with patients' ratings of dyspnea (r=0.29; 95% confidence interval (CI), 0.22 to 0.35). In contrast, the FEV1 was minimally correlated with patients' ratings of overall health (r=0.10; 95% CI, 0.03 to 0.17). The FEV1 needed to differ by 4% predicted for the average patient to stop rating his or her dyspnea as “about the same” and start rating his or her dyspnea as either “a little bit better” or “a little bit worse” relative to other patients (95% CI, 1.5 to 6.5). This was equivalent to the average patient's FEV1 increasing by 112 mL (starting from 975 mL and ending at 1,087 mL).

Conclusions

Some statistically significant differences in the FEV1 are so small that they may not represent important differences in symptoms for the average patient with severe COPD; an awareness of the smallest difference in FEV1 that is noticeable to patients can help clinicians interpret the effectiveness of symptomatic treatments.

Section snippets

Setting

We recruited individuals with severe COPD who were participating in a supervised respiratory rehabilitation program. Participants admitted to the rehabilitation program came from the community, were receiving maximal medical therapy, and had no other active medical conditions (including congestive heart failure, significant anemia, or substantial obesity).5 Most individuals in the rehabihtation program had been referred because of reduced exercise tolerance, inability to perform activities of

RESULTS

We recruited 112 patients in groups of between 5 and 13 individuals (15 groups). The typical participant was 67 years old with symptomatic COPD for 10 years. Half were men and half were women. The distributions of age, gender, and spirometry were similar to the general characteristics of patients enrolled in the respiratory rehabilitation program.7 Patients varied in their severity of disease, with FEV1 values ranging from 12% predicted to 86% predicted. The mean FEV1 was 35% predicted (SD=16),

DISCUSSION

Dyspnea in patients with chronic lung disease is a complex subjective phenomenon accompanied by complex neurophysiology.8 In this study, we estimated the threshold at which a difference in FEV1 tended to be associated with a small but noticeable difference in breathing for the average patient with severe COPD. By comparing objective differences in FEV1 to subjective comparison ratings of breathing ability, we found that the threshold for the FEV1 was about 112 mL for patients who had an average

REFERENCES (26)

  • CohenJ
    (1969)
  • RedelmeierDA et al.

    Assessing the clinical importance of symptomatic improvements: an illustration in rheumatology

    Arch Intern Med

    (1993)
  • WellsGA et al.

    Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

    J Rheumatol

    (1993)
  • Cited by (99)

    • Should continuous rather than single-injection interscalene block be routinely offered for major shoulder surgery? A meta-analysis of the analgesic and side-effects profiles

      2018, British Journal of Anaesthesia
      Citation Excerpt :

      Importantly, we found no evidence for CISB-related complications or catheter-related technical issues in this systematic review. While CISB was associated with a small impairment in physiological indices of respiratory function that seemed to be well-tolerated by healthy study participants (very low evidence),68 this may be clinically relevant in high-risk subjects.69,70 The effects of CISB on motor function could not be ascertained because of the variability in outcome measures in a small number of trials.

    • Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT<sup>®</sup>)

      2013, Respiratory Medicine
      Citation Excerpt :

      Although Herpel et al. suggested that FEV1 changes >0.225 L likely represent true changes in lung function,7 we demonstrated that changes greater than 0.280–0.320 L would be required to exceed the normal between-test variation. However, FEV1 changes over time are biased by training in spirometry and patient characteristics, while changes within the normal variation may still represent a clinically meaningful result when accompanied by symptom changes.16 Therefore, some experts have suggested that the minimal clinically important difference between two measurements is best estimated by the standard error, which would be around 0.180 L for UPLIFT®.6,17

    View all citing articles on Scopus

    This project was funded through an Ontario Career Scientist award (Dr. Redelmeier), an Ontario Ministry of Health Research Personnel Development Fellowship award (Dr. Min), and grants from the Ontario Thoracic Society, the National Cancer Institute of Canada, and the West Park Hospital Foundation (Dr. Redelmeier).

    View full text